Arsenic in chicken feed may pose health risks to humans

Apr 09, 2007

Pets may not be the only organisms endangered by some food additives. An arsenic-based additive used in chicken feed may pose health risks to humans who eat meat from chickens that are raised on the feed, according to an article in the April 9 issue of Chemical & Engineering News.

Roxarsone, the most common arsenic-based additive used in chicken feed, is used to promote growth, kill parasites and improve pigmentation of chicken meat. In its original form, roxarsone is relatively benign. But under certain anaerobic conditions, within live chickens and on farm land, the compound is converted into more toxic forms of inorganic arsenic. Arsenic has been linked to bladder, lung, skin, kidney and colon cancer, while low-level exposures can lead to partial paralysis and diabetes, the article notes.

Use of roxarsone has become a topic of increasing controversy. A growing number of food suppliers have stopped using the compound, including the nation’s largest poultry producer, Tyson Foods, according to the article. Still, about 70 percent of the 9 billion broiler chickens produced annually in the U.S. are fed a diet containing roxarsone, the article points out.

Complicating the issue is the fact that no one knows the exact amount of arsenic found in chicken meat or ingested by consumers who frequently eat chicken. “Neither the Food and Drug Administration nor the Department of Agriculture has actually measured the level of arsenic in the poultry meat that most people consume,” according to the article.

The National Chicken Council, a trade association that represents the U.S. chicken industry, claims there is “no reason to believe there are any human health hazards” associated with the use of roxarsone.

Source: American Chemical Society

Explore further: Treatment for overactive bladder and irritable bowel syndrome advanced through pioneering research

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Biologists reprogram skin cells to mimic rare disease

18 hours ago

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

Student seeks to improve pneumonia vaccines

Aug 20, 2014

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

User comments : 0